Ethenzamide

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L929ZCK4BF. European Medicines Agency schedules Ethenzamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07274MIG. Ethenzamide generally arises in the molecular formula C9H11NO2. The term ETHENZAMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, no10, 1977, list 17.) ETHENZAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ethenzamide under HS 29242995 and SITC 51479. As of Q4 2014, ETHENZAMIDE remains the US FDA Preferred Term for this commodity. Ethenzamide bears US NLM identifiers UMLS ID C0059708 and NCI Concept Code C87323. SMILES: O(C1C(CCCC1)C(=O)N)CC.